Please login to the form below
influenza
This page shows the latest influenza news and features for those working in and with pharma, biotech and healthcare.
Sanofi backs vaccines unit with €350m Canadian facility
Last year’s performance was driven by Sanofi’s paediatric and influenza vaccines, and the pharma company has also been investing in the latter category.
Latest news
-
Long-serving R&D head Bischofberger to leave Gilead
Austria-born Bischofberger - who rose to prominence as one of the inventors of Roche’s big-selling influenza drug Tamiflu (oseltamivir) - will leave the company fully in July after 28 years
-
Pfizer’s leukaemia drug Mylotarg backed for use in EU
peramivir) infusion for the treatment of uncomplicated influenza.
-
UK biotech Vaccitech raises £20m for universal flu shot
for a standalone flu vaccine, according to analysts at Edison, which notes that the primary endpoint in the study will be reduction in the influenza-like illness (ILI) rate.
-
Through the Looking Glass
In fact, lower levels of health literacy have been consistently associated with increased hospitalisations, greater emergency care use, lower use of mammography, lower receipt of influenza vaccine, poorer ability to take
-
Sanofi earmarks €170m for new French vaccines facility
The new Val de Reuil facility will allow Sanofi Pasteur to increase supply of its new quadrivalent influenza vaccine VaxigripTetra. ... Philippe Luscan, executive vice president, global industrial affairs, Sanofi, said: “Our investment underlines
More from news
Approximately 20 fully matching, plus 192 partially matching documents found.
Latest Intelligence
-
Deal Watch February 2016
coli and influenza, and in toxicology applications. While Abbott already has a significant diagnostics presence with global sales in 2015 in this segment of $4.6bn, it forecasts that the acquisition
-
Another lost decade for research?
diseases that cause significant morbidity and mortality, such as influenza and malaria, but remain difficult to vaccinate against.
-
Pharma deals in June 2015
85. BioCryst Pharmaceuticals/ CSL. RAPIVAB (peramivir injection) for the treatment of influenza (marketed).
-
Wearables: the tangible product of the patient revolution
The opportunity is massive - in the public health arena, there exists the possibility that outbreaks of diseases such as Ebola or influenza could be seen and stopped before they become critical.
-
Deal Watch table for October 2014
318. Novartis/CSL. Asset purchase. Influenza vaccines. 275. Five Prime/GSK. Expansion of collaboration.
More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.
Latest appointments
-
Germany's Ventaleon names biotech entrepeneur CEO
patients suffering from serious infections such as influenza to get better, faster.
-
Dr Michael Watson appointed as president of Valera
Dr Watson brings twenty years of vaccines expertise to the role and has broad experience in the development and licensing of vaccines for conditions such as smallpox, encephalitis and influenza.
-
NDA Group appoints Bill Griffiths as general manager, UK
systems teams as well as a specialist influenza vaccines unit.
-
Takeda appoints head of vaccines development
Boslego will be responsible for accelerating global vaccine development activities with a focus on lead development programmes for dengue, norovirus and seasonal influenza.
-
MHRA chairman steps down
He was previously chair of the MHRA's Commission of Human Medicines and the Department of Health's Scientific Pandemic Influenza Committee.
More from appointments
Approximately 0 fully matching, plus 11 partially matching documents found.
Latest from PMHub
-
To track disease, follow the money
The way that influenza spreads can be tracked by tools such as Flusurvey,(1) which produces rapidly-updated heatmaps of illness across the country.
-
Influenza
Agency: BASTARD. LONDON. Product: Self Promotion. Client: Self Promotion. Therapy area: Self Promotion. View the PMHub profile for: BASTARD. LONDON.
-
To track disease, follow the money
The way that influenza spreads can be tracked by tools such as Flusurvey,(1) which produces rapidly-updated heatmaps of illness across the country.
More from PMHub
Approximately 2 fully matching, plus 1 partially matching documents found.
Featured jobs
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
- FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...
-
EXCELLENT DAY RATES AVAILABLE
-
Scientific Director
-
Great salary and bebefits
- Editor > Senior Editor – Medical Education – London
-
Very competitive with excellent benefits
-
Senior Medical Writer
-
Great salary and bebefits
-
Account Manager, Healthcare PR
-
£40, 000 – £42, 000 great benefits and bonuses
- Principal Medical Writer, Medical Communications, Relocate to Ca...
-
Excellent Salary
- Senior Medical Writer, Medical Communications, Relocate to Cardi...
-
Excellent Salary
- Account Manager – Med Comms – London
-
Salary TBC
- Senior / Principal Regulatory Writer – Home Working - UK or US
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
- FREELANCE Account Manager – Creative Healthcare Advertising – Lo...
-
SUPERB DAY RATES AVAILABLE
- Head of Operations/ BUD, Healthcare PR, London – Excellent leade...
-
Excellent Package
- Senior Account Manager / Account Director
-
Great salary and bebefits
- Senior Account Manager – Med Comms – Kent
-
Salary TBC
-
Senior Programme Executive
-
Salary TBC
-
Senior Medical Writer
-
Great salary and benefits
Subscribe to our email news alerts
PMHub
Conversis
Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...
Latest intelligence
- No Voice, No Choice
- Adelphi Research UK’s insights help to campaign for change in the Mental Health Act...
- Pharma’s isolated islands of innovation
- With service design and technology often failing the patient, why perspective on improving outcomes need to change...
- Uncertainty, austerity and Brexit
- What does it mean for the life science sector?...
Quick links
Infographics
